BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21757432)

  • 1. The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population.
    Grabellus F; Worm K; Sheu SY; Siffert W; Schmid KW; Bachmann HS
    J Clin Pathol; 2011 Nov; 64(11):1021-4. PubMed ID: 21757432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
    Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
    Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology.
    Dufresne A; Alberti L; Brahmi M; Kabani S; Philippon H; Pérol D; Blay JY
    BMC Cancer; 2014 Aug; 14():632. PubMed ID: 25174682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and significance of M541L single nucleotide polymorphism in the central European cohort of gastrointestinal stromal tumor patients.
    Jasek K; Grendar M; Stanclova A; Malicherova B; Kasubova I; Burjanivova T; Szepe P; Ciccocioppo R; Rodrigo L; Prosecky R; Kruzliak P; Plank L; Lasabova Z
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1203-1215. PubMed ID: 33044628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma.
    Krasagakis K; Metaxari M; Zervou M; Stathopoulos EN; Eberle J; Kanitakis J; Georgoulias V; Krüger-Krasagakis S; Tavernarakis N; Tosca AD
    Anticancer Res; 2011 Mar; 31(3):807-11. PubMed ID: 21498700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis.
    Dufresne A; Bertucci F; Penel N; Le Cesne A; Bui B; Tubiana-Hulin M; Ray-Coquard I; Cupissol D; Chevreau C; Perol D; Goncalves A; Jimenez M; Bringuier PP; Blay JY
    Br J Cancer; 2010 Aug; 103(4):482-5. PubMed ID: 20664593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects.
    Nagata H; Worobec AS; Metcalfe DD
    Exp Clin Immunogenet; 1996; 13(3-4):210-4. PubMed ID: 9165275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
    Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan.
    Hongyo T; Li T; Syaifudin M; Baskar R; Ikeda H; Kanakura Y; Aozasa K; Nomura T
    Cancer Res; 2000 May; 60(9):2345-7. PubMed ID: 10811105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series.
    Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM
    J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
    Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
    Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
    J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6.
    Atanasova S; Shipkova M; Svinarov D; Mladenova A; Genova M; Wieland E; Oellerich M; von Ahsen N
    Ther Drug Monit; 2007 Feb; 29(1):6-10. PubMed ID: 17304144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population.
    Alahdab YO; Eren F; Giral A; Gunduz F; Kedrah AE; Atug O; Yilmaz Y; Kalayci O; Kalayci C
    Neurogastroenterol Motil; 2012 Jan; 24(1):27-30. PubMed ID: 21951831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLA2G6 variant in Parkinson's disease.
    Tomiyama H; Yoshino H; Ogaki K; Li L; Yamashita C; Li Y; Funayama M; Sasaki R; Kokubo Y; Kuzuhara S; Hattori N
    J Hum Genet; 2011 May; 56(5):401-3. PubMed ID: 21368765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-kit expression in dedifferentiated and well-differentiated liposarcomas; immunohistochemistry and genetic analysis.
    Tayal S; Classen E; Bemis L; Robinson WA
    Anticancer Res; 2005; 25(3B):2215-20. PubMed ID: 16158966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S; Chen LR; Wang HJ; Chen SZ
    Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.